PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsPrurigo
MeSH D011536 - prurigo
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012871:Skin diseases
36 Companies
17 Drugs
$
Success rate
D011536: 
Prurigo
2 Companies
2 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
SanofiDupilumab Dupixent  2017-09-26   
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
10%
1/10
Phase 3
0%
0/2
Approved: 0Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Galderma
Nemolizumab,
Ademetionine,
Aspartame
Sanofi
Dupilumab,
Corticoids,
Q2w
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use